N3-PEG3-vc-PAB-MMAE (C007B-379330)

Catalog No.: C007B-379330
Mfr. No.: N658995-10mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $974.07

List Price: $1,082.30

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

N3-PEG3-vc-PAB-MMAE is a synthesized agent-linker conjugate for ADC that incorporates the MMAE (a tubulin inhibitor ) and 3-unit PEG linker. N3-PEG3-vc-PAB-MMAE shows potent antitumor activity.Appearance:SolidIC50& Target:AuristatinIn Vitro:Monomethyl auristatin E (MMAE; SGD-1010) is a synthetic derivative of Dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) to treatBiological Activity:N3-PEG3-vc-PAB-MMAE is a synthesized agent-linker conjugate for ADC that incorporates the MMAE (a tubulin inhibitor ) and 3-unit PEG linker. N3-PEG3-vc-PAB-MMAE shows potent antitumor activity. Specification: 0.98 Molecular Formula: C67H109N13O16 Molecular Weight: 1352.66

UPC:: 51201651
Condition:: New
Availability:: 8-12 weeks
Weight:: 1.09 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: N658995-10mg
Product Size:: 10mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."